Latest filing published 14 Oct 2025 for Fennec Pharmaceuticals INC., €4,320. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Chris A. Rallis in Fennec Pharmaceuticals Inc., where the filings describe the role as board member. Over a trading history stretching from 21 October 2021 to 10 October 2025, the count stands at 22 filings.
On the market, this insider has only sold: 8 sales, €75k in total. Other entries cover 14 option exercises.
Most recently, on 14 October 2025, the filings show an option exercise worth €4,320 in Fennec Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations